{
  "resourceType": "StructureDefinition",
  "id": "cibmtr-additional-peri-transplant-medication",
  "url": "http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-additional-peri-transplant-medication",
  "name": "CIBMTR_AdditionalPeriTransplantMedication",
  "title": "CIBMTR Additional Drugs in Peri-Transplant Period",
  "status": "draft",
  "description": "CIBMTR Additional Drugs Given in the Peri-Transplant Period. Drugs may be given during the peri-transplant period to prevent transplant-related complications, such as liver injuries or to facilitate engraftment.",
  "fhirVersion": "4.0.1",
  "kind": "resource",
  "abstract": false,
  "type": "Medication",
  "baseDefinition": "http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-medication",
  "derivation": "constraint",
  "differential": {
    "element": [
      {
        "id": "Medication.code.coding",
        "path": "Medication.code.coding",
        "binding": {
          "strength": "extensible",
          "valueSet": "http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-addition-peri-transplant-vs"
        }
      }
    ]
  }
}
